TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,730,975 | -7.6% | 8,089,315 | 0.0% | 0.10% | -9.5% |
| Q2 2023 | $24,591,518 | +61.7% | 8,089,315 | 0.0% | 0.10% | +69.4% |
| Q1 2023 | $15,207,912 | +84.3% | 8,089,315 | 0.0% | 0.06% | +100.0% |
| Q4 2022 | $8,251,101 | +38683.1% | 8,089,315 | 0.0% | 0.03% | -60.8% |
| Q3 2022 | $21,275 | -99.9% | 8,089,315 | 0.0% | 0.08% | -34.7% |
| Q2 2022 | $36,483,000 | -54.2% | 8,089,315 | 0.0% | 0.12% | -40.1% |
| Q1 2022 | $79,599,000 | -35.6% | 8,089,315 | 0.0% | 0.20% | -34.8% |
| Q4 2021 | $123,686,000 | +12.8% | 8,089,315 | 0.0% | 0.31% | +26.5% |
| Q3 2021 | $109,691,000 | -7.7% | 8,089,315 | 0.0% | 0.24% | -8.6% |
| Q2 2021 | $118,832,000 | – | 8,089,315 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |